肌少性肥胖与老年人认知功能受损的关联:美国国家健康与老龄化趋势调查数据
该纵向二次数据分析纳入5822名基线无认知受损的≥65岁美国社区老年人,随访8年。相比无肌少症和肥胖者,单纯肌少症(HR 1.60;95%CI 1.42-1.80)和肌少性肥胖(HR 1.20;95%CI 1.03-1.40)与认知功能受损风险升高相关,单纯肥胖则无差异(HR 0.98;95%CI 0.82-1.16)。
要点
- 肌少症和肌少性肥胖均与老年人长期认知功能受损风险增加相关。
- 单纯肥胖未显示与认知功能受损风险独立相关。
- 肌少症与肥胖之间无显著交互作用。
核心结论
- 肌少症和肌少性肥胖与老年人长期认知功能受损风险升高相关,单纯肥胖无此关联。
研究设计与样本
- 纵向二次数据分析,使用美国国家健康与老龄化趋势调查,纳入5822名基线无认知受损、有握力和BMI数据的≥65岁社区老年人,随访8年。
主要发现
- 基线肌少性肥胖患病率为12.9%,随访时21.2%的参与者出现认知功能受损。
- 与无肌少症和肥胖者相比,单纯肥胖者认知受损风险无差异(HR 0.98;95%CI 0.82-1.16)。
- 肌少症者认知受损风险显著升高(HR 1.60;95%CI 1.42-1.80)。
- 肌少性肥胖者认知受损风险显著升高(HR 1.20;95%CI 1.03-1.40)。
- 肌少症与肥胖之间无显著交互作用。
关键数值与推荐
- 肌少症定义采用Foundation for the National Institutes of Health Sarcopenia Project握力切点:男性<35.5 kg,女性<20 kg。
- 肥胖采用标准BMI分类定义。
- 认知功能受损定义为Alzheimer's Disease-8评分或即时/延迟回忆、定向、画钟测验、日期/人物回忆中任一受损。
临床怎么用
- 对≥65岁老年人可评估肌少症和肥胖,识别肌少性肥胖以分层认知功能受损风险。
- 肌少症和肌少性肥胖老年人可能需要关注认知功能变化并进行长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The prevalence of obesity with sarcopenia is increasing in adults aged ≥65 years. This geriatric syndrome places individuals at risk for synergistic complications that leads to long-term functional decline. We ascertained the relationship between sarcopenic obesity and incident long-term impaired global cognitive function in a representative US population. DESIGN: A longitudinal, secondary data set analysis using the National Health and Aging Trends Survey. SETTING: Community-based older adults in the United States. PARTICIPANTS: Participants without baseline impaired cognitive function aged ≥65 years with grip strength and body mass index measures. METHODS: Sarcopenia was defined using the Foundation for the National Institutes of Health Sarcopenia Project grip strength cut points (men <35.5 kg; women <20 kg), and obesity was defined using standard body mass index (BMI) categories. Impaired global cognition was identified as impairment in the Alzheimer's Disease-8 score or immediate/delayed recall, orientation, clock-draw test, date/person recall. Proportional hazard models ascertained the risk of impaired cognitive function over 8 years (referent = neither obesity or sarcopenia). RESULTS: Of the 5822 participants (55.7% women), median age category was 75 to 80, and mean grip strength and BMI were 26.4 kg and 27.5 kg/m2, respectively. Baseline prevalence of sarcopenic obesity was 12.9%, with an observed subset of 21.2% participants having impaired cognitive function at follow-up. Compared with those without sarcopenia or obesity, the risk of impaired cognitive function was no different in obesity alone [hazard ratio (HR) 0.98; 95% confidence interval (CI) 0.82-1.16]), but was significantly higher in sarcopenia (HR 1.60; 95% CI 1.42-1.80) and sarcopenic obesity (HR 1.20; 95% CI 1.03-1.40). There was no significant interaction term between sarcopenia and obesity. CONCLUSIONS: Both sarcopenia and sarcopenic obesity are associated with an increased long-term risk of impaired cognitive function in older adults.
引用
- Batsis JA, Haudenschild C, Roth RM, et al. Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey. J Am Med Dir Assoc. 2020. PMID: 34248422. doi:10.1016/j.jamda.2020.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。